Results 151 to 160 of about 28,675 (247)

Inpatient care for people with multiple sclerosis - a secondary data analysis in Germany between 2019 and 2024. [PDF]

Neurol Res Pract
Viebahn SM, Nothnik E, Raths S, Krohn M, Brüggemann F, Herr T, Süße M, Flöel A, Ziemssen T, Fleßa S, Grothe M.   +10 more
europepmc   +1 more source

Standard Model Imaging in the Brain and Spinal Cord of MS Patients: Initial Assessment and Comparison to Diffusion Tensor Imaging

NMR in Biomedicine, Volume 39, Issue 8, August 2026.
DTI and SMIfw diffusion models applied in persons with multiple sclerosis revealed region‐specific sensitivity to microstructural injury, but performance differed by anatomical region. SMIfw neurite density fraction demonstrated high sensitivity and reliability in both the brain and spinal cord, whereas DTI measures such as fractional anisotropy and ...
Atlee Witt, Alicia E. Cronin, Bailey Busher, Isabella Stuart, Grace Sweeney, Kristin P. O'Grady, Seth A. Smith, Samantha By, Kurt Schilling   +8 more
wiley   +1 more source

Adherence to risk minimization measures for alemtuzumab use in multiple sclerosis: a drug utilization study in four European countries. [PDF]

Ther Adv Neurol Disord
de Keijzer C, E JY, Yang Q, Gitonga R, Hiller D, Jurgensen S, Salloum N, Cunha-Santos J, Hoogewys-Cynober E, Vinet L, Chirieac M, Benzerdjeb H, Thoene D, Ziemssen T, Drahota J, Horáková D, Brown W, Hobart J, Robertson NP, Hakkarainen KM, Sinnott SJ.   +20 more
europepmc   +1 more source

Abstracts

Molecular Oncology, Volume 20, Issue S1, Page 1-692, August 2026.
Abstracts submitted to the ‘EACR 2026 Congress: Innovative Cancer Science’, from 08–11 June 2026 and accepted by the Congress Organising Committee are published in this Supplement of Molecular Oncology, an affiliated journal of the European Association for Cancer Research (EACR).
wiley   +1 more source

Reported Characteristics of Anaphylaxis Associated With Glatiramer Acetate: A Pharmacovigilance Analysis of the FDA and Canadian Databases

Pharmacology Research &Perspectives, Volume 14, Issue 4, August 2026.
ABSTRACT The FDA has mandated a Boxed Warning for glatiramer acetate (GA) due to the risk of serious anaphylactic reaction. This study aimed to characterize the reported features of GA‐associated anaphylaxis. Data mining was performed using the Reporting Odds Ratio (ROR) in the FDA Adverse Event Reporting System (FAERS) database (Q1 2004–Q1 2025) and ...
Tailei Nie, Hongyu Liu, Chuanxu Cheng, Jian Li, Jiajing Lu   +4 more
wiley   +1 more source

Metabolic changes in normal-appearing white matter associate with MRI measures of disease burden in relapsing-remitting multiple sclerosis over three years. [PDF]

Sci Rep
Zöchner A, Bogner W, Dal-Bianco A, Strasser B, Hangel G, Rommer PS, Niess E.   +6 more
europepmc   +1 more source

Safety and Effectiveness of Dimethyl Fumarate in Japanese Patients With Multiple Sclerosis: Subgroup Analysis of Older Patients and Patients Switching From Fingolimod or Natalizumab Using 2‐Year Post‐Marketing Surveillance Data

Clinical and Experimental Neuroimmunology, Volume 17, Issue 3, August 2026.
In a 2‐year post‐marketing surveillance of Japanese patients with multiple sclerosis, dimethyl fumarate (DMF) showed manageable safety, with no new concerns identified; lymphocyte decreases were more frequent in older patients and those switching from fingolimod.
Ichiro Nakashima, Toshiyuki Fukazawa, Kazumasa Yokoyama, Takashi Yamamura, Hirofumi Ochi, Michihiro Kanda, Yayoi Sato, Ryusuke Sato, Haruki Makioka, Aya Tsuchiya, Takahiko Saida   +10 more
wiley   +1 more source

A CSF disease-associated macrophage signature defines progressive multiple sclerosis. [PDF]

J Neuroinflammation
Börsch AL, Riethues F, Schulte-Mecklenbeck A, Wang X, Heming M, Lu IN, Müller-Miny L, Wiendl H, Gross CC, Bernard-Valnet R, Meyer Zu Hörste G.   +10 more
europepmc   +1 more source

Bridging the Pregnancy Knowledge Gap: A Real‐World Analysis of Medication Use and Drug–Drug Interaction Risk in Crohn's Disease and Multiple Sclerosis

Clinical and Translational Science, Volume 19, Issue 8, August 2026.
ABSTRACT The exclusion of pregnant individuals from clinical trials has resulted in a significant medical knowledge gap for this population. Leveraging real‐world data (RWD) provides a critical window into the prevalence and use of medications during pregnancy.
Jacqueline Williams, Rucha Sane, Amita Joshi, Kit Wun Kathy Cheung, Bianca Vora   +4 more
wiley   +1 more source

Using a Person‐Centred Approach to Adapt a Digital Therapy for Inflammatory Bowel Disease (COMPASS‐IBD)

Health Expectations, Volume 29, Issue 4, August 2026.
ABSTRACT Background Patient and public involvement (PPI) enhances the relevance, acceptability and implementation potential of interventions. Objective To describe the adaptation of a cognitive‐behavioural therapy (CBT) based intervention (COMPASS) into an inflammatory bowel disease (IBD)‐specific version (COMPASS‐IBD), in partnership with individuals ...
Sophie Harding, Harinder Singh, Katrin Hulme, Natasha Seaton, Abigail Wroe, Alexa Duff, Joanna Hudson, Rona Moss‐Morris, Annie S. K. Jones   +8 more
wiley   +1 more source